Gene expression in low glycemic index diet - Impact on metabolic control

Forum of Nutrition

Volumn 60, Issue , 2007, Pages 127-139

  Takeda, Eiji ^a   Arai, Hidekazu ^a   Muto, Kazusa ^a   Matsuo, Kaoru ^a   Sakuma, Masae ^a   Fukaya, Makiko ^a   Yamanaka Okumura, Hisami ^a   Yamamoto, Hironori ^a   Taketani, Yutaka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL; CONFERENCE PAPER; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; GLYCEMIC INDEX; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POSTPRANDIAL STATE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLYCEMIC INDEX; HUMANS; OXIDATIVE STRESS; POSTPRANDIAL PERIOD; PPAR ALPHA; PPAR GAMMA;

EID: 34547969506     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000107089     Document Type: Conference Paper

References (40)

1. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV: Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981;34:362-366.
2. Jenkins DJA, Wolever TMS, Jenkins AL, Josse RG, Wong GS: The glycaemic response to carbohydrate foods. Lancet 1984;ii:388-391.
3. Wolever TMS, Jenkins DJA, Jenkins AL, Josse RG: The glycemic index: methodology and clinical implications. Am J Clin Nutr 1991;54:846-864.
4. Brand-Miller J, Nantel G, Slama G, Lang V: Glycemic Index and Health: the Quality of the Evidence. Paris, John Libbey Eurotext, 2001.
5. Augustin LS, Franceschi S, Jenkins DJA, Kendall CWC, La Vecchia C: Glycemic index and chronic disease: a review. Eur J Clin Nutr 2002;56:1049-1071.
6. Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240.
7. Opperman AM, Venter CS, Oosthuizen W, Thompson RL, Vorster HH: Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 2004;92:367-381.
8. McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF: Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 2004;27:538-546.
9. Dahlqvist A, Auricchio S, Semenza G, Prader A: Human intestinal disaccharidases and hereditary disaccharide intolerance: the hydrolysis of sucrose, isomaltose, palatinose (isomaltulose), and 1,6-α-oligosaccharide (isomalto-oligosaccharide) preparation. J Clin Invest 1963;42:556-562.
10. Lina BA, Jonker D, Kozianowski G: Isomaltulose (palatinose): a review of biological and toxicological studies. Food. Chem Toxicol 2002;40:1375-1381.
11. Kawai K, Okuda Y, Yamashita K: Changes in blood glucose and insulin after an oral palatinose administration in normal subjects. Endocrinol Jpn 1985;32:933-936.
12. Arai H, Mizuno A, Sakuma M, Fukaya M, Matsuo K, Muto K, Sasaki H, Matsuura M, Okumura H, Yamamoto H, Taketani Y, Doi T, Takeda E: Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the second-meal effect in healthy men. Metabolism 2007;56:115-121.
13. Arai H, Mizuno A, Matsuo K, Fukaya M, Sasaki H, Arima H, Matsuura M, Taketani Y, Doi T, Takeda E: Effect of a novel palatinose-based liquid, balanced, formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism 2004;53:977-983.
14. Matsuo K, Arai H, Muto K, Fukaya M, Sato T, Mizuno A, Sakuma M, Yamanaka-Okumura H, Sasaki H, Yamamoto H, Taketani Y, Doi T, Takeda E: Antiobesity effect of long-term palatinose-based formula (Inslow) administration mediated by hepatic PPAR-α and adipocyte PPAR-γ gene expression. J Clin Biochem Nutr 2007, in press.
15. Kabir M, Rizkalla SW, Quignard-Boulange A, Guerre-Miflo M, Boillot J, Ardouin B, Luo J, Slama G: A high glycemic index starch diet affects lipid storage-related enzymes in normal and to a lesser extent in diabetic rats. J Nutr 1998;128:1878-1883.
16. Motojima K, Passilly P, Peters J M, Gonzalez F J, Latruffe N: Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 1998;273:16710-16714.
17. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W, Grimaldi P, Staels B, Yamamoto T, Auwerx J: Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 1995;270:19269-19276.
18. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S: The mouse peroxisome proliferator-activated. receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 1992;11:433-439.
19. Fasshauer M, Paschke R: Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46:1594-1603.
20. Ricquier D, Bouillaud F: The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 2000;345:161-179.
21. Dalgaard LT, Pedersen O: Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 2001;44:946-965.
22. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731-737.
23. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama- Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946.
24. Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W: Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 2003;88: 2714-2718.
25. Grimble RF: Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002;5: 551-559.
26. Bjorntorp P: The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996;20:291-302.
27. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:419-422.
28. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
29. MatsuokaT, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y: Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 1997;99:144-150.
30. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL: Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 2001;50:404-410.
31. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N: Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998;47: 1562-1569.
32. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-2551.
33. Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X, Achten R, Verslype C, Diehl AM: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003;163:1301-1311.
34. Bjorntorp P: Growth hormone, insulin-like growth factor-I and lipid metabolism: interactions with sex steroids. Horm Res 1996;46:188-191.
35. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9.
36. Anisman H, Zacharko RM: Depression as a consequence of inadequate neurochemical adaptation in response to stressors. Br J Psychiatry 1992;160(suppl 15):36-43.
37. Markus CR, Panhuysen C. Tuiten A, Koppeschaar H, Fekkes D, Peters M: Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task? Appetite 1998;31:49-65.
38. Nonogaki K, Strack A, Dallman M, Tecott L: Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2c receptor gene. Nat Med 1998;4:1152-1156.
39. Parillo M, Riccardi G: Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidences. Br J Nutr 2004;92:7-19.
40. Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J, Lindstrom J, Louheranta A: Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr 2004;7:147-165.